Organovo +16% even as report says 3D printing of organs could be banned

|About: Organovo Holdings, Inc. (ONVO)|By:, SA News Editor

Shares of Organovo (ONVO +16%) continue to surge despite an IBTimes UK report that says research firm Gartner predicts 3D bioprinted human organs will soon become a reality, which could ignite calls to ban the technology.

The Gartner report raises moral and ethical questions about whether organs should be printed using non-human cells or a mix of human and non-human cells, and whether there is a difference between this and genetically modified food crops.

ONVO, deeply involved in such research, said this morning it has performed its first 3D Liver tissue delivery and expects to begin the commercial launch of its 3D Liver tissue product before year-end.